# The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed

> **NCT00534677** · PHASE4 · COMPLETED · sponsor: **Aga Khan University** · enrollment: 320 (actual)

## Conditions studied

- Portal Hypertension
- Cirrhosis
- Hematemesis
- Melena

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Octreotide

## Key facts

- **NCT ID:** NCT00534677
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2007-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534677, "The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00534677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*